4 protocol(s) meet the specified criteria
PI: Sanoff, Hanna Kelly
Protocol No.TitleStatus
CALGB80702A Phase III Trial of 6 versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer Open (affiliates only)
MCC17651Multi institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.Open
PB-1201A Multicenter Randomized Phase II Study of NPC-1C in Combination with Gemcitabine and nab-Paclitaxel versus Gemcitabine and nab-Paclitaxel alone in Patients with Metastatic or Locally Advanced Pancreatic Cancer Previously Treated with FOLFIRINOXOpen
UGIC-14072Regorafenib in Adults >/=70 Years with Metastatic Colorectal Cancer: A Phase II StudyOpen